FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, precision agriculture, and professional pest, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

FMC achieves record Q4 results, eyes growth amid cost challenges

FMC's strong Q4 performance and full-year results reflect growth across regions and product segments. While facing short-term challenges like cost pressures and supply disruptions, the company is poised for revenue and EBITDA growth in 2023. Strategic initiatives in sustainability, innovation, and market expansion position FMC for long-term success.

FMC reports solid Q1 earnings, focuses on growth and sustainability

FMC's Q1 performance was solid, driven by revenue growth and adjusted EBITDA increase, despite regional challenges.
The company's focus on new products, market access, and sustainability aligns with future growth strategies.
Challenges in Latin America and Asia require strategic management, while opportunities lie in cash flow growth and market expansion.
Overall, FMC's outlook remains positive with a commitment to innovation, sustainability, and financial resilience.

FMC reports Q2 sales decline, anticipates rebound in 2024

FMC faced challenges in Q2 with sales decline due to volume drop, impacting EBITDA and free cash flow guidance for 2023.
Despite challenges, the company is adapting by controlling costs, investing in R&D, and focusing on new product sales for long-term growth.
Opportunities lie in stabilizing inventory levels, focusing on R&D pipeline, and anticipating a rebound in cash flow as market conditions normalize.
FMC remains confident in managing through demand shocks, with a focus on customer intimacy, commercial operations, and market access for growth.

FMC reports Q3 revenue decline, eyes growth in 2024

FMC's Q3 performance saw revenue and EBITDA decline significantly, impacting free cash flow. Despite challenges in working capital and inventory levels, the company is focusing on growth strategies for its products. Opportunities lie in potential price increases, new product introductions, and positive sales growth projections for 2024.

FMC projects revenue growth in 2024 despite regional challenges

FMC faces challenges in certain regions but maintains a strong margin and optimistic revenue guidance for 2024, driven by new products.
The company's focus on operational efficiency through global restructuring and inventory management positions it for future growth.
Despite short-term adjustments, FMC's long-term targets remain intact, with expectations of accelerated growth in 2025.
Strong commercial performance with new products and strategic resilience in core businesses highlight FMC's potential for sustained growth.

FMC Corporation reports robust Q3 earnings, anticipates strong Q4 growth

FMC's Q3 performance showcased resilience and growth despite regional challenges. The company's focus on new product development and cost savings initiatives bodes well for future profitability. With strong Q4 projections, FMC is poised for continued success in the coming quarters.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

LOS ANGELES, CA / ACCESSWIRE / December 4, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE: FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Reminds Investors in FMC Corporation with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in FMC Corporation with Losses In Excess of $100,000 to Contact the Firm

NEW ORLEANS , Dec. 1, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 8, 2024 to file lead plaintiff applications in a securities class action lawsuit against FMC Corporation (NYSE: FMC), if they purchased or otherwise acquired the Company's shares between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of Pennsylvania.

FMC SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against FMC Corporation - FMC

NEW YORK , Dec. 1, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of FMC Corporation (NYSE: FMC) between November 2, 2022 and October 20, 2023, both dates inclusive (the "Class Period"), of the important January 8, 2024 lead plaintiff deadline. SO WHAT: If you purchased FMC securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages FMC Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FMC

If you purchased or acquired securities in FMC between November 2, 2022 and October 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FMC.

FMC INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options

LOS ANGELES, CA / ACCESSWIRE / November 30, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in FMC Corporation with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 29, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in FMC Corporation with Losses of $100,000 to Contact the Firm

SAN DIEGO , Nov. 28, 2023 /PRNewswire/ -- DiCello Levitt LLP announces that purchasers or acquirers of FMC Corporation (NYSE: FMC) common stock between November 1, 2022 and October 30, 2023, inclusive (the "Class Period") have until January 8, 2023, to seek appointment as lead plaintiff of the FMC class action lawsuit. The lawsuit charges FMC and certain of its senior executive officers with violations of the Securities Exchange Act of 1934.

DiCello Levitt LLP Announces Investor Class Action Lawsuit Filed Against FMC Corporation (NYSE: FMC) and Lead Plaintiff Deadline

NEW ORLEANS , Nov. 27, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 8, 2024 to file lead plaintiff applications in a securities class action lawsuit against FMC Corporation (NYSE: FMC), if they purchased or otherwise acquired the Company's shares between November 2, 2022 and October 20, 2023, inclusive (the "Class Period").

FMC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against FMC Corporation - FMC

NEW YORK , Nov. 27, 2023 /PRNewswire/ -- Attention FMC Corporation ("FMC") (NYSE: FMC) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between November 1, 2022 and October 30, 2023. If you suffered a loss on your investment in FMC, contact us about potential recovery by using the link below.

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind FMC Investors of a Lead Plaintiff Deadline of January 8, 2024

LOS ANGELES, CA / ACCESSWIRE / November 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in FMC Corporation with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 8, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) common stock between November 1, 2022 and October 30, 2023, inclusive (the “Class Period”). If you suffered a loss on your FMC investments or would like to inquire about potentially pursuing claims to.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FMC Corporation (FMC)

NEW YORK--(BUSINESS WIRE)---- $FMC #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against FMC Corp. (“FMC” or “the Company”) (NYSE: FMC) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired FMC securities between Nove.

FMC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that FMC Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

FMC Corporation's stock has experienced a significant sell-off, down 20% since my last bullish article was written in September. The company's Q3 earnings were disappointing, with a 29% YoY decrease in revenue attributed to global inventory destocking. FMC sees a path to strong growth after 2023, with a focus on debt reduction and outperforming the market in revenue by 1.5 to 2x by 2033.

Down 60%, FMC Corp. Has Become An Ultra Deep Value Play

LOS ANGELES, CA / ACCESSWIRE / November 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

IMPORTANT JANUARY DEADLINE: The Schall Law Firm Encourages Investors in FMC Corporation with Losses of $100,000 to Contact the Firm

SAN DIEGO--(BUSINESS WIRE)---- $FMC #FMCCorporation--FMC Corporation (FMC) Misled Investors Regarding Patent Protection for its Flagship Products.

FMC Corporation (FMC) Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the FMC Corporation Class Action

FMC Corp (FMC) outlines its new strategic growth plan, including a focus on strengthening grower relationships, expanding the Plant Health business and accelerating R&D pipeline development.

FMC Corp (FMC) Unveils Plan for Sustainable Profitable Growth

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming January 8, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) common stock between November 1, 2022 and October 30, 2023, inclusive (the “Class Period”). Investors suffering losses on their FMC investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FMC Corporation (FMC)

LOS ANGELES, CA / ACCESSWIRE / November 19, 2023 /The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in FMC Corporation with Losses of $100,000 to Contact the Firm

If you purchased or acquired securities in FMC between November 2, 2022 and October 30, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/FMC.

FMC SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In FMC To Contact Him Directly To Discuss Their Options

FMC Corporation announced on Friday that it is conducting a strategic review of its non-core assets, which includes a potential sale of its non-crop product line, Global Specialty Solutions.  The crop protection products maker has seen its earnings for most of the year hurt by a slowdown in demand for herbicide and pesticides.

FMC eyes non-core asset sales to boost profitability

LOS ANGELES, CA / ACCESSWIRE / November 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE:FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2022 and October 20, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before January 8, 2024.

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in FMC Corporation with Losses of $100,000 to Contact the Firm

Shares in German kidney dialysis company Fresenius Medical Care (FMC) rose on Friday after Societe Generale said that disruption of the dialysis market by the obesity and diabetes drugs class known as GLP-1 is unlikely.

FMC shares up after broker hints dialysis market disruption by GLP-1s unlikely

Provides preliminary 2024 outlook1 including revenue of $4.65 billion to $4.85 billion, adjusted EBITDA of $1.025 billion to $1.125 billion and free cash flow conversion of greater than 100 percent Initiates three-year rolling financial goals with 2026 revenue expected to be $5.5 billion to $6.0 billion and adjusted EBITDA of $1.3 billion to $1.5 billion Announces strategic review of non-core assets including potential sale of FMC's non-crop product line, Global Specialty Solutions Ten-year revenue aspiration includes approximately $2 billion from Plant Health business and approximately $2 billion from four new active ingredients in R&D pipeline PHILADELPHIA , Nov. 17, 2023 /PRNewswire/ -- FMC Corporation (NYSE:FMC) hosted its Investor Day on November 16 at FMC corporate headquarters in Philadelphia where the company introduced its new strategic growth plan, reviewed three-year financial goals and longer-term financial aspirations through 2033, and provided its preliminary outlook for 2024.  The company also outlined cost savings targets and key elements that will drive sustained profitable growth.

FMC Corporation outlines new strategic growth plan

LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of FMC Corporation (FMC) Investors.

News for FMC Stock (FMC)